This study was to test the hypothesis that a newly identified JAK3-INSL3 fusion transcript may contribute to constitutive JAK3 activation and lymphomagenesis in MF/SS CTCL. Here, JAK3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.